GlassScriptPhysician profile
Janice L Wells
NPI 1467755306
$1,502.52
in general payments reported to CMS, 2019-2025
16 companies · $749 in 2025
The $749 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $148 · 2024: $605 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,502.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $247.16 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $243.18 | 2024-2025 | Breztri, Airsupra |
| Abbott Laboratories | $239.44 | 2023-2025 | Freestyle Libre |
| Novo Nordisk INC | $221.13 | 2023-2025 | Ozempic, Rybelsus |
| Idorsia Pharmaceuticals US INC | $67.32 | 2023-2024 | Quviviq |
| Dexcom, INC. | $63.96 | 2024-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $61.99 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $56.75 | 2024 | |
| Pfizer INC. | $54.83 | 2023-2024 | |
| Astellas Pharma US INC | $53.74 | 2025 | Veozah |
| Amgen INC. | $45.98 | 2024-2025 | Repatha, Otezla, Repatha |
| Otsuka America Pharmaceutical, INC. | $42.71 | 2024-2025 | Rexulti |
| Glaxosmithkline, LLC. | $32.71 | 2023-2024 | Arexvy, Shingrix |
| Globus Medical, INC. | $32.43 | 2025 | Senza |
| Pharmacosmos Therapeutics INC. | $20.65 | 2025 | Monoferric |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $18.54 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.